BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.
To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.
To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.
Reprints
As new multimillion-dollar gene therapies continue hitting the market, it's unclear how small employers, state Medicaid programs, and the rest of the health system will absorb such large costs all at once, Axios reports. The Food and Drug Administration recently approved two multimillion-dollar gene therapies from Bluebird Bio Inc. – one costing $2.8 million and the other $3 million.
1. FTC refunds customers for fraudulent health plans sold by Benefytt
2. Health systems consider dropping Medicare Advantage plans due to financial losses
3. UnitedHealth faces rising lawsuits following Change Healthcare cyberattack
4. MedPAC calls for 'major overhaul' of Medicare Advantage policies
5. Medicare to cover Novo Nordisk's weight-loss drug for heart patients
6. AT&T faces second lawsuit over $8 billion pension risk transfer